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We carried out a resequencing project that examined 552 kb of sequence from each of 46 individual HLA haplotypes representing a diversity of
HLA allele types, generating nearly 27 Mb of fully phased genomic sequence. Haplotype blocks were defined extending from telomeric of HLA-F
to centromeric of HLA-DP including in total 5186 MHC SNPs. To investigate basic questions about the evolutionary origin of common HLA
haplotypes, and to obtain an estimate of rare variation in the MHC, we similarly examined two additional sets of samples. In 19 independent HLA-
A1, B8, DR3 chromosomes, the most common HLA haplotype in Northern European Caucasians, variation was found at 11 SNP positions in the
3600-kb region from HLA-A to DR. Partial resequencing of 282 individuals in the gene-dense class III region identified significant variability
beyond what could have been detected by linkage to common SNPs.
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Sequence analysis, DNAGenetic and evolutionary studies of the immune response
have often centered on the major histocompatibility complex
(MHC), comprising the class I, II, and III regions, and including
the class I and II genes that encode the human leukocyte antigen
(HLA) molecules involved in immune recognition [1]. In
addition to these fundamental immune response genes, the
MHC region contains over 140 genes, about 40% of which
function in a variety of ways contributing to both innate and
adaptive immunity [2]. For the past several decades, the unusual
levels of polymorphism at the HLA class I and II loci have
facilitated a large number of studies of the relationships between
genetic variability among specific MHC loci and interesting
immunological phenotypes related to autoimmunity, transplan-
tation, and infectious disease [3–7]. Despite many significant
efforts in search of the causative relationship class I or II
polymorphism might have with disease, none of the highly⁎ Corresponding author.
E-mail address: geraghty@fhcrc.org (D.E. Geraghty).
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doi:10.1016/j.ygeno.2005.11.020associated HLA alleles have been demonstrated directly as
causative of disease. This is most likely due to the fact that the
HLA class I and class II genes are not always necessary and are
never sufficient to cause disease (e.g., most A1, B8, DR3-
carrying individuals will not develop type 1 diabetes), and
therefore variability at other loci, within the MHC or elsewhere
in the genome, must contribute to disease phenotype [8].
With the allelic polymorphism among the MHC class I and II
genes now being very well defined [9], attention has turned to
the other MHC genes and also to whole MHC sequences for
further information on new variability relevant to immunity and
disease [10,11]. Several haplotype maps of the human MHC
have been described recently [12,13], characterizing the linkage
disequilibrium relationships among several thousand single-
nucleotide polymorphisms (SNPs) and adding cohesiveness to
our knowledge of the underlying linkage disequilibrium (LD)
block structure long recognized within the human MHC
[14,15]. Using haplotype-tagged SNPs [16,17], it is possible
to sample a subset of SNPs within a haplotype block and derive
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tagged SNPs across the MHC can be identified at sufficient
density it should be possible to perform association and linkage
analysis in comparisons with disease and controls to detect
common variants outside of HLA class I and II loci that are
associated with disease. Exactly such studies are now being
carried out in several labs assuming the common disease/
common variant hypothesis will hold true in these searches [19].
These searches are usually limited to SNP typing technology,
which cannot detect previously unknown variation. An equally
plausible hypothesis recognizes that there are a much larger
number of rare SNPs in the genome and although it is usually
not possible to associate them individually with disease, it may
be possible to associate the aggregate of rare SNPs. Indeed,
exactly such a case has been found in the analysis of obesity in
which direct sequencing of well-chosen candidate genes led to
the identification of numerous rare alleles causing both
syndromic and common obesity [20]. Similarly, rare DNA
sequence variants were shown to contribute collectively to
variation in plasma levels of high-density lipoprotein choles-
terol [21]. Although the possibility of detecting rare variants
using common variant tagged SNPs and SNP typing technology
has been raised [22], such methods may currently apply only in
the hypothetical due to practical constraints in predicting
haplotypes with certainty.
These considerations provided further motivation to under-
stand better the genetic diversity of the MHC and to develop
tools that could be routinely used to identify functional variants
in the MHC other than the class I and II loci. Derivative data and
tools could then be used both to aid clinical studies and to
advance our understanding of the evolutionary history of
humans through comparative genomic analysis. Toward these
ends, we established a resequencing project that examined 552
kb of MHC sequence from each of 48 individual chromosomes
representing a diversity of HLA allele types, generating nearly
27 Mb of genomic sequence. From these data we were able to
build haplotype blocks extending telomeric of HLA-F to the
centromeric sequences near HLA-DP defining linkage relation-
ships among several thousand new common variants in the
MHC. To answer basic questions about the evolutionary origin
of disease-related MHC haplotypes and to demonstrate the
effectiveness of the unique approach used for SNP genotyping,
we similarly examined 19 examples of the most common MHC
haplotype HLA-A1, B8, DR3, a haplotype that is known to be
associated with autoimmune disease, including type 1 diabetes
(T1D). The results of these studies further motivated an
extended look at the variability that can be found beyond that
detected using common SNPs as markers. These data and
methods together are discussed in terms of their suitability for
detecting polymorphism in the MHC relevant to immunological
phenotypes and therefore fundamental to studies of infectious
disease, autoimmunity, and transplantation.
Results
The term haplotype has long been used to refer to
collections of HLA alleles, spanning the entire MHC [23].This term refers to the HLA genes, which are routinely typed
in transplantation, and while two individuals with the same
HLA alleles are said to have the same MHC haplotypes, they
do not necessarily contain identical sequences throughout the
MHC. The question as to the degree of similarity between
chromosomes with the same MHC haplotype is an open area
of research and is the same as asking how often particular
HLA alleles come together through recombination and
whether one contiguous MHC has been maintained through
time [24]. The term haplotype can also refer to sequence
identity between two individuals over a short distance. We
use the term in both ways throughout and clarify the usage
when necessary.
MHC SNPs
PCR resequencing of 557 segments (amplicons) averaging
1 kb in length spread throughout the MHC yielded 552 kb of
DNA sequence for each of 48 chromosomes (Fig. 1) for a
total of approximately 27 million bp of MHC sequence.
Nearly all of this sequence was derived from unique
sequences, including gene, pseudogene, promoter, and other
unique sequences of unknown function. From these data it
was possible to assemble completely phased SNP data for
almost all of the regions spanned by the 48 chromosomes,
excepting 2% of the data from families as described under
Materials and methods. In that regard, almost all of the
haplotype information for the 5186 SNPs identified is
deduced and not inferred. Three of the 48 chromosomes
had the same HLA-A, B, C, DRB1, DQB1 genotype, and
thus the total dataset represented 46 distinct HLA haplotypes,
providing what is in essence a partial genomic sequence
(∼15% of the complete sequences, 30% of the unique
sequences) of 48 different 4.0-Mb MHC haplotypes. Each of
these 48 haplotypes was derived from 557 amplicons, and
each amplicon in turn can be described in terms of its allelic
variation of its constituent SNPs. Twenty-eight of the
amplicons contained no variation at all, while the remaining
amplicons contained an average of 9.7 SNPs. A simple
breakdown of the distribution of these SNPs over genes,
pseudogenes, and other sequences within the MHC is
summarized in Table 1. With a sample size of 48
chromosomes, the 5186 SNPs represent 87% of the SNPs
with a minor allele frequency at or above 1% and 99% of the
SNPs present at or above 5% [25] in the human population in
the regions sequenced.
All of the SNPs included in the analysis lie at least 10 kb
outside of the sequences flanking the classical class I and II HLA
genes. As is indicated in Fig. 1 and in agreement with previous
studies the SNP density near the class I and II loci is very high
[26,27]. In addition, the HLA genes themselves being the most
polymorphic loci in the genome are highly adequate markers for
these regions. Therefore, considering this and the technical
complexities of analyzing the high-density SNPs near the class I
and II genes, these adjacent SNP data were not included in this
analysis (although data were acquired from some of these
regions). Overall there were 9.4 SNPs per sequenced kilobase
Fig. 1. An overview of the density of variant sites in MHC assembled from 48 chromosomes. Gene locations are indicated beneath each segment and MHC numbering
is according to the convention established by the Sanger Center MHC consensus located at http://www.vega.sanger.ac.uk [10]. Vertical orange bars on the line labeled
Amplicons denote location of the 557 amplicons analyzed. Each amplicon spans on average 1 kb representing about 15% of the total MHC sequence or 1 kb of
sequencing per 7.1 kb. The graph on the SNP density bar represents the measured number of variant sites among 46 MHC haplotypes, with the vertical axis
representing the number of SNPs/kb.
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these 48 chromosomes we need to correct for the fact that the
amplicons are more closely spaced in regions of low SNP
density. A simple estimate allows each amplicon to represent the
number of SNPs between half the distance to the next most
telomeric amplicon and half the distance to the next mostcentromeric amplicon. Using this estimation we find that the
average number of SNPs per kilobase throughout the MHC is
13.3 and there are a total of 51,990 SNPs between these 48
chromosomes. There was an average of 2.4 SNPs/kb identified
between any two individual chromosomes among the 48
analyzed.
Table 1
MHC SNP and amplicon distribution from 48 phased chromosomes
SNPs Amplicons
Genes 1188 188
Pseudogenes 921 52
Unknown function a 3077 317
Total 5186 557
a Including multispecies conserved sequences.
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amplicons
To define the local MHC structure and identify the
minimal number of informative amplicons capable of defining
regional LD, we computed the linkage disequilibrium index
(LDI) between adjacent amplicons, inferred their haplotype-
block structures, and identified haplotype-tagging amplicons
(Fig. 2). Because these data were fully phased, multiple SNP
alleles within an amplicon were treated as a single locus with
multiple alleles, allowing us to evaluate LD among ampliconsFig. 2. Observed linkage disequilibrium index (LDI) and haplotype blocks in the MHC
of 0 corresponds to linkage equilibrium. One value for the LDI is plotted for each of
that point with the following amplicon. Amplicons are then grouped into haplotype bl
as the amplicon in the areas with white background. Tagged amplicons within block
analysis only if there are more than five copies, to ensure the robustness of haplotyrather than individual SNPs. While D′ is often used, it cannot
be easily adapted to work with multiple SNP loci or multiple
amplicons. Instead, we used a modified measure of linkage
disequilibrium, known as the linkage disequilibrium index
based upon the concept of entropy (see Materials and
methods).
Upon calculating LDI we identified a set of haplotype-
tagging amplicons, providing an economy that will allow the
simultaneous detection of other SNPs in most segments of the
MHC that are in linkage disequilibrium. The variance in block
size observed was very large, extending from a few kilobases to
over 150 kb, as illustrated in Fig. 2, in which it is evident that
the large blocks include regions with previously well estab-
lished linkage disequilibrium (e.g., HLA-DR-DQ) [28]. One
interesting aspect of the block distribution is contained in the
class III region where amplicons were less likely to fit into a
haplotype block, resulting in shorter, sparsely distributed
blocks, consistent with significant levels of recombination. A
number of secondary associations with MHC-related diseases
have been detected in this region [8].. An LDI value of 1 corresponds to perfect linkage disequilibrium, while a value
the amplicons, and each plotted value corresponds to the LDI of the amplicon at
ocks, shown in gray. Blocks that contain only one amplicon are indicated simply
s are red points. Note that haplotypes within each amplicon are included in the
pe block detection.
Fig. 3. The A1, B8, DR3 haplotypes are highly conserved between HLA-Q and
HLA-DR. Variability between 19 8.1 chromosomes is presented with similar
analysis of 19 HLA chromosomes analyzed in this study. The numbers of SNPs
at continuous positions extending over the 4.0-Mb MHC region are plotted on
the vertical against positions within the MHC on the horizontal. The solid red
line represents analysis of the 19 8.1 chromosomes and the dashed green line is
derived from 19 randomly chosen chromosomes from the original set of 48.
Table 2
Tabulation of blocks and block sizes in the MHC derived from 46 HLA
haplotypes
Block size
(No. of
amplicons)
Count Percentage Block size in kilobases
Mean Min Max Mean No. of
tagged amplicons
1 74 48.37 – – – 1
2 26 16.99 10.3 2.7 48.5 2
3 16 10.46 13.4 7.1 25.9 2.9
4 15 9.80 24.0 6.2 58.4 3.1
5 8 5.23 30.1 14.0 74.6 3.6
6 2 1.31 46.6 45.2 48.1 3.5
7 2 1.31 41.5 33.9 49.1 3.5
8 4 2.61 87.9 35.3 198.9 4.8
10 2 1.31 67.4 40.0 94.8 3.5
11 1 0.65 77.4 77.4 77.4 5
12 1 0.65 76.2 76.2 76.2 5
16 1 0.65 175.5 175.5 175.5 3
20 1 0.65 150.5 150.5 150.5 4
Note that haplotypes within each amplicon are included in the analysis only
if there are more than five copies, to ensure the robustness of haplotype
block detection.
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identified among the 48 phased chromosomes studied based on
410 amplicons, each selected because it containedmore than five
haplotypes (Table 2). Seventy-four (48%) of the 153 blocks
consisted of a single amplicon, and 26 (17%) consisted of 2
amplicons. The average size of all 2-amplicon blocks was 13.4
kb with a range of 2.7–48.5 kb. The number of tagging
amplicons for the largest blocks plateaus near 4, as shown in
Table 2. For example, the largest block is composed of 20
amplicons, and sequencing of only 4 of the 20 amplicons yields
95% of the SNP information of the entire block. In contrast, the
8 5-amplicon blocks still require sequencing of an average of 3.6
amplicons to yield maximum information. All but 1 of the 26 2-
amplicon blocks required sequencing of both amplicons for full
information reporting. The total number of tagged amplicons for
this dataset is 303 of 410 (74%) (Fig. 2) with 55 of the 107
unnecessary amplicons residing within the 6 largest blocks. The
average size of the blocks containing 2 or more amplicons was
28 kb, which is similar to other regions in the human genome
[29] and to two recent MHC SNP-typing studies [12,30].
MHC SNP analysis of the HLA-A1, B8, DR3 common extended
haplotype
The relatively high prevalence of a few common extended
conserved (CEH) haplotypes in human populations has long
been a subject of interest with regard to their relationships to
immune selection and immune-mediated disease [15]. The most
frequent of these is the HLA-A1, B8, DR3, found at a frequency
of about 7% in European Caucasians. Three copies of the 8.1
haplotype were present within our original set of 48 chromo-
somes, and analysis of these revealed virtually identical
sequences throughout most of the MHC. To examine further
this haplotype toward understanding its origin and potentially
its age in the human population, we added 16 8.1 chromosomes
from unrelated individuals to this analysis. A second goal was toidentify the boundaries of conservation within each of these
CEH chromosomes, should they be contained within the
regions that were sampled, to provide an initial focus for
MHC SNP analysis of potential relevance to disease.
When the 19 8.1 chromosomes were analyzed at all 557
amplicon positions, it was immediately apparent that the region
from HLA-A to HLA-DQ was highly conserved, while the
variability outside of these loci was indistinguishable from any
random set of 19 unrelated chromosomes, indicating that
recombination has frequently taken place beyond these
boundaries (Fig. 3). Virtually overlapping patterns of SNP
variability were observed centromeric of HLA-DQ including
DP. Conversely, the sequences beyond HLA-A were highly
conserved until beyond the HLA-F locus, where variability
overall was low. Of 317 SNPs identified among the 19 8.1
chromosomes, only 11 SNPs were found in the conserved region
between HLA-A and DQ defined by 393 kb of measured
sequence. Thus the diversity among the 19 8.1 chromosomes, a
total of 11 SNPs, represents an average of 3.8 SNPs per pair of
chromosomes over the 2.6-Mb region between HLA-A and
HLA-DQ. These data are consistent with previous studies of LD
between the HLA class I, class II, and class III (C4, Bf, TNF)
genes, demonstrating that the Caucasian 8.1 haplotype is highly
conserved and thus its preponderance (about 7% of the
Caucasian haplotypes) is likely due to a profound expansion
that must have occurred in relatively recent times. Assuming that
SNPs accrue at a rate of 3/genome/generation [31], one can
calculate how many generations are required for there to be an
11/19 chance that one SNP appears in a given number of bases.
Every base has a 1 × 10−9 chance of being polymorphic in a
given generation; there were 393 × 103 bases sequenced between
HLA-A and HLA-DR; after t generations the likelihood that we
will see an SNP in that stretch is (1 × 10−9) (393 × 103) t, and the
number of generations required to accumulate an 11/19 chance is
t = (11/19)/[(1 × 10−9) (393 × 103)]. With 1470 generations at 16
years/generation we estimate that these haplotypes could have
Fig. 4. Identification of SNPs within the 8.1.3 haplotypes. The positions of the
HLA class I and II genes within the MHC are indicated on the line by larger
vertical bars and each is identified beneath with the corresponding letter
designating the HLA locus. Blue arrows below the line mark the positions of
amplicons that contained SNPs unique to the 8.1 chromosomes, red arrows mark
additional positions that differed among some of the 8.1 chromosomes in
polymorphic positions known from the original 45 non-8.1 chromosomes, and
green vertical lines on the line indicating the MHC mark positions where the
genotype was the same for all of the 8.1 chromosomes examined but differed
from all of the other 45 HLA haplotypes analyzed in this study.
Table 4
Rare SNP analysis in 18 amplicons in the MHC class III region
Gene Sequencing SNPs NS minor allele
prevalence g
CDS bp a bp seq'd b Non-
CDS c
CDSd SS e NS f b1.1% N1.1%
BAT2 1753 (27%) 4122 16 11 4 7 2 (4) 5 (399)
C6orf29 875 (41%) 1816 4 6 2 4 3 (3) 1 (230)
MICA 200 (17%) 811 13 4 3 1 0 1 (147)
AGER 466 (38%) 998 3 3 0 3 3 (7) 0
NCR3 453 (75%) 895 2 4 2 2 1 (6) 1 (9)
C6orf25 419 (63%) 1163 2 4 2 2 2 (2) 0
C2 399 (18%) 1030 3 1 0 1 1 (1) 0
DOM3Z 462 (39%) 808 2 3 2 1 1 (4) 0
C4B 859 (16%) 1848 4 5 4 1 1 (5) 0
566 W.P. Smith et al. / Genomics 87 (2006) 561–571diverged from a single, common ancestor 23,500 ± 10,000 years
ago, where the uncertainty is a 95% confidence value and is
dominated by the sampling error from the small number of
chromosomes involved.
In Table 3 the numbers of SNPs among the 8.1 chromosomes
and among all haplotypes examined are broken down over the
entire region surveyed and within the conserved region between
HLA-A and DQ. This breakdown resulted in three groupings,
SNP alleles that were identified among the 8.1 chromosomes and
distinguished from one another, SNP alleles that were unique to a
subset of the 8.1 chromosomes, and SNP alleles that were unique
to all of the 8.1 chromosomes. The alleles of SNPs unique to all
8.1 haplotypes analyzed include 25 positions that do not vary
among the 19 chromosomes but of which the genotype is
different from that found in any of the other 45 chromosomes
analyzed (e.g., at one position a G is found in all 8.1
chromosomes and a T in all other chromosomes examined).
Thus, any one of these 25 SNP positions could be used to identify
the 8.1 chromosomes among the sample size of 46 haplotypes
reported here. Of the 11 additional SNPs differing among the 8.1
chromosomes, 8 of these are unique among the 46 HLA
haplotypes to a subset of the 8.1 chromosomes. These 8.1-
specific SNPswere distributed across theMHCwith no evidence
of clustering that might suggest mutational hot spots (Fig. 4).
Rare SNPs in the MHC
Because the approach used in this study for genotyping was
direct sequencing it was possible to detect rare SNPs, including
those identified in the 8.1 analysis as discussed above. One of
the reasons for continuing to use this method beyond an initial
SNP discovery phase was evident from the data acquired during
the sequencing of 8.1 chromosomes. In this case, if only
common SNPs identified in the preliminary analysis of 48
chromosomes had been used to analyze the set of 19 8.1
chromosomes, only 3 of the 11 SNPs (Table 3) would have been
identified. When extrapolating from the 15% of the region
sampled, we can predict that there are about 73 SNPs that would
be missed in the 8.1 haplotypes using a common variant
association approach to detect SNPs.
The degree to which rare SNPs would not be detected using
methods for SNP typing other than direct sequencing motivated
a further study to estimate better the number of rare SNPs found
per kilobase per individual. For this study, 15 ampliconTable 3
Complete
MHC
HLA-A to
DRB1
A. SNP frequencies in the HLA-A1, B8, DR3 (8.1) haplotype a
Number of SNPs 317 11
Number of variant amplicons 108 11
B. Genotypes found only in 8.1 haplotypes among the 48 haplotypes examined
Unique genotypes possessed by all
8.1 chromosomes
25 23
Unique genotypes possessed by a subset
of the 8.1 chromosomes
21 8
a Analysis included 21 8.1 haplotypes.sequences were sampled in 282 unrelated individuals mostly
of Caucasian origin. From the 4.2 Mb of sequence derived, 45
SNPs were identified that were not observed among the
previously established set of 64 SNPs identified in the same
group of amplicons (Table 4). Of these, 36 were present at less
than 1.1% of the population sampled. These SNPs could be
further broken down into substitutions affecting coding
sequences and noncoding sequences. The group of coding
SNPs was equally weighted toward synonymous versus
nonsynonymous substitutions, with 25 synonymous and 22
nonsynonymous. Only 7 of the 22 coding SNPs were present in
more than 3% of the chromosomes. The total number of
nonsynonymous substitutions in this group of chromosomes
was 3.9%, or 7.5% of the individuals examined (all except one
were heterozygous). This rate of nonsynonymous codingBF 308 (13%) 1152 6 2 2 0 0 0
BAT3 374 (30%) 724 5 2 2 0 0 0
VARS2 430 (13%) 1216 1 1 1 0 0 0
NEU1 565 (15%) 1121 1 1 1 0 0 0
Total 62 47 25 22 14 (32) 8
282 cell lines in 18 amplicons were analyzed.
a Coding sequence (CDS) base pairs (bp) sequenced; the percentage of the
total CDS from each gene is in parentheses.
b Total base pairs sequenced in the region of the gene.
c SNPs that are not located in CDS.
d Total SNPs in CDS.
e Synonymous CDS SNPs (SS) do not affect amino acid sequence.
f Nonsynonymous CDS SNPs (NS) alter amino acid sequence.
g Breakdown of rare and common NS and total number of chromosomes that
have these SNPs.
567W.P. Smith et al. / Genomics 87 (2006) 561–571substitutions suggests a potential source of functional variation
that, when considered cumulatively, could significantly con-
tribute to phenotype.
Discussion
These studies were aimed at establishing and validating tools
for examining genomic diversity across the human MHC,
ultimately with the aim of using them in investigations of
disease associations with the MHC. The tools in this case
constituted the primer pairs that defined amplicons of unique
sequence that were useful to derive data from any number of
individual MHCs. The data generated represent the SNPs
identified from the analysis of 48 distinct MHC haplotypes. Our
goal was to define amplicons spread throughout the MHC at a
relatively even spacing that would together comprise a
significant portion of the MHC within the limits of practical
constraints. Since the MHCs examined were either derived from
homozygous HLA cells or based on the study of pedigree-
defined HLA haplotypes, it was possible to deduce haplotypes
for nearly all of the SNP data and phase this with the known
HLA allelic information. The defined amplicons and data can be
used to focus on the region as a whole or on any subset toward
clinical and disease mapping applications in the HLA region.
Establishing linkage disequilibrium statistics among the
5186 SNPs spanning the MHC identified in this study can give
an indication of recombination and evolutionary history of the
MHC [12,30] but, importantly for practical studies, will allow
for the selection of a subset of tagged SNPs that can be used to
impart efficiency in any genotyping strategy [18,32]. To
calculate LD we used the LDI as a potentially more powerful
statistical method since it can accommodate more than two
adjacent SNPs when testing for LD. In addition, instead of
tagged SNPs we calculated LDI based on amplicons whereby
the alleles at a given amplicon were tested for LD with adjacent
amplicons downstream and upstream. This analysis was more
appropriate for our study, since the chromosomal haplotype for
each amplicon was fully recovered when we sequenced the
amplicon, in contrast to SNP typing assays, which yield
information only about the targeted base. Therefore, similar to
the use of tagged SNPs, using sequence-based methods for
querying tagged amplicons will yield information about other
amplicons that are in LD, since the LDI gives information on
how well the haplotypes or blocks present in one amplicon
predict those in another. Although the multilocus ability of the
LDI is most appropriate for our investigations involving
resequencing, our SNP data are present in dbSNP and the
entire set of over 250,000 genotypes is available in dbMHC
(under the handle “FHCRC”), allowing any desired measure of
LD to be applied to this dataset.
Cullen et al. have previously characterized linkage and
haplotype blocks within the MHC class II region by genotyping
sperm with microsatellites to map recombination locations [33].
Spots of high recombination should correspond to regions of
low LDI, and all three of the spots described by Cullen et al. are
consistent with the LDI map generated by the current dataset. A
200-kb segment of class II was mapped in more detail usingSNPs [34] with similar results, indicating that SNP searches for
recombination hot spots will yield results similar to those of
sperm typing with microsatellites. A larger study of recombi-
nation in the MHC mapped the entire region [35] and found one
additional hot spot, located between LTA and BAT2, which was
also found to be a region of low LDI in our analysis. Contrary to
our results, however, that study found that the class III region is
a relatively cool recombination area, while we find a low LDI
throughout this region. Interestingly, while Cullen et al. did not
observe any double recombination in the MHC, our analysis
showed that cell line PLH (IHW090407) underwent a double
recombination event between HLA-A and HLA-B extending
from HCGIX-4 to HLA-E. It is not known if this was the result
of double recombination in one generation or two separate
recombinations over more than one generation.
Linkage disequilibrium among HLA loci has been a
hallmark of the MHC, and the idea of block structures for the
MHC was extensively analyzed and discussed well before a
similar focus was brought to bear on the human genome
[23,36–38]. One of the most interesting MHC haplotypes
described is the HLA-A1, B8, DR3 haplotype, which is
common among European Caucasians and is associated with
several immune-mediated diseases including type 1 diabetes
[3,6,39]. By sequencing 19 8.1 chromosomes from unrelated
individuals we were able to obtain evidence of a rapid
expansion of an ancestral chromosome in relatively recent
times. This means that the HLA-A1, B8, and DR3 alleles are in
strong linkage disequilibrium due to a recent expansion rather
than having been derived from distinct haplotypes through
multiple independent events in which selection drove the
linkage of these alleles. This finding could be interpreted to
mean that there is not necessarily any functional significance to
the linkage of the three loci, but rather that possibly only one of
the A1, B8, DR3 loci was under strong positive selection, which
drove an expansion in recent times. Consistent with this
possibility is the observation of a number of other conserved
haplotypes that include DR3 but have lost HLA-A1 or HLA-B8.
Using simple assumptions, we estimated the age of the 8.1
haplotype at about 23,500 years, a time that is well within
estimates of the human migration and expansion into Europe.
These considerations might suggest then that around this time,
strong selection for part or all of the 8.1 haplotype began. In that
regard, the recent hypothesis that type 1 diabetes may have been
selected for as an adaptive measure in cold climates raises an
intriguing speculation [40]. In that study, cryoprotective
adaptation based on higher glucose levels is proposed to have
protected ancestral northern Europeans from the effects of the
ice age around 14,000 years ago. Therefore, when life
expectancy was short, factors predisposing to type 1 diabetes
are proposed to have provided a survival advantage. This time
frame is within the limits of error of our estimate of the
beginning of the expansion of the 8.1 chromosome. It may be
possible to define more precisely the period and the length of
time such selection was operating by comparative study of 8.1
chromosomes with other HLA-DR3 and HLA-B8 positive
haplotypes and building phylogenetic trees based on the sharing
of SNP-defined construction of MHC blocks.
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interesting in their own right, the extreme similarities among
the 8.1 chromosomes identify an important consideration in the
design of strategies to identify genes residing in the MHC, other
than the class I or II loci, that are associated with disease, of
which a number of efforts are ongoing [41]. As mentioned, the
8.1 chromosome is not only highly represented in the European
Caucasians, but it is also significantly associated with type 1
diabetes. Therefore it is of interest to compare type 1 diabetic
8.1 chromosomes with 8.1 chromosomes derived from normal
controls. However, our findings indicate that the most
commonly proposed approach, using haplotype-tagged com-
mon SNPs to map new loci, may not be satisfactory to identify
what would presumably be SNPs that are unique to the T1D 8.1
chromosomes. Of 11 SNPs we identified that were 8.1 specific,
only 3 of these would be eligible for inclusion in a common
SNP panel and none of the 11 were in the typing panel used in
the most recent MHC SNP study [12]. Based on the number of
SNPs found unique to 8.1 and considering that we sampled 15%
of the conserved region, we can calculate that there are as many
as 53 8.1-specific SNPs among the 19 chromosomes tested here.
Therefore, direct sequence analysis may be the only method that
will be adequate for detecting differences between disease-
associated and normal 8.1 chromosomes or to rule out any
differences and thus conclude that there are no MHC resident
loci other than the class II genes associated with T1D, at least
between HLA-A and DQ.
Our analysis of the 8.1 CEH also suggests the importance of
defining the extent of similarity across the MHC and the value
of defining boundaries similarly for other known disease-
associated CEHs. Definition of boundaries can provide a focus
on the appropriate regions that can be applied toward answering
similar questions about those disease associations. For example,
the sequences immediately centromeric of HLA-DQ appear to
have undergone significant recombination among all the initial
48 chromosomes and to a very similar extent among the group
of 19 8.1 chromosomes (Fig. 3), indicating that loci within this
region may not be candidates for association with T1D.
Alternatively, this could be interpreted to focus studies more
aggressively toward proving or disproving that there is no
significant T1D association for any of the SNP blocks
centromeric to DQ with T1D. Thus further examination of
both normal and disease-associated 8.1 chromosomes might
focus a search on specific regions, in addition to the need to rely
on sequence-based methods for genotyping. From our prelim-
inary analysis of other CEHs, the 8.1 haplotype provides an
example of the type of information we can expect from a
detailed study of several other CEHs (unpublished data).
Our preliminary work defining MHC variation was carried
out using sequencing for SNP discovery, as are most current
state-of-the-art approaches for SNP discovery. We extended
the use of this approach to genotyping in the MHC rather than
relying on other fixed-platform SNP typing methods for the
reasons alluded to above to test the hypothesis that differences
that do exist between CEHs may not be identifiable by SNP
typing platforms that detect only common tagged SNPs. In
addition, it is apparent from several studies that a number ofdifferent rare variants from multiple genes can collectively
contribute toward disease [20,21]. This includes the variants
that are individually rare in the population and have very low
heterozygosity but whose total number is large enough to
provide many polymorphisms in a pedigree. A consideration
of the potential number of distinct phenotypes associated with
the MHC, which contains over 50 genes with immune-related
functions, makes the possibility of a similar rare-SNP
hypothesis for MHC disease associations quite plausible. In
this study 105 common SNPs of varying frequencies in the
gene-dense class III region were examined, and 45 new SNPs
were identified through the use of sequence-based analysis.
The majority of these were rare (b1%), but their combined
cumulative frequency added significantly to the overall
variability within the population. In addition, a significant
number of these were nonsynonymous changes in coding
sequences and thereby could have a direct functional
consequence. Thus, resequencing can provide access to this
abundant pool of rare variants—something that is impossible
to achieve with conventional SNP maps using fixed-platform
technologies.
The flexibility of the resequencing approach means that new
information can be a routine by-product of sequence-based
genotyping without any redesign in the underlying technology
for acquiring genetic data. In fact, the ability to develop new
assays is routine, with minimal costs, and can be added at any
stage in a study. Instead of looking at over a thousand SNPs
simultaneously on a single individual, as is the case for some
fixed-platform methods, the amplicon-based approach can
provide the flexibility and convenience of targeting selected
MHC regions or genes. This approach is also adaptable to a
change in the SNP composition to be queried in response to new
information acquired as a study progresses. Such changes might
require an entirely new application of some fixed-based SNP
platforms to the study population or possibly the application of
a different technology altogether to deal with the smaller
number of SNPs. Sequenced-based genotyping requires nothing
new as the application of new amplicons would seamlessly
integrate into the ongoing process. In that regard, studies of
disease association in the MHC may benefit from direct
knowledge of the DNA sequence to make the most effective use
of the extensive diversity that is the MHC.
Materials and methods
Cell lines used
A total of 47 Epstein–Barr virus-transformed B cell lines available through
the International Histocompatibility Working Group (IHWG.org) were used in
this study for primary SNP discovery (see online Supplementary Material).
Twenty-seven of these were selected from a set originally part of the 10th
International HLA Workshop (IHWS) panel identified as individually contain-
ing MHCs that were identical by descent (IBD) and were chosen as a group that
represented diversity in their HLA types. Of these, 23 proved to contain
homozygous sequences over the entire MHC region studied and 3 were
homozygous from our most telomeric amplicon up to and including the HLA-
DR region. Two of the 27 were found to have undergone intra-HLA
recombination. BRIP (IHW09044) was homozygous only in a 1.5-Mb region
extending from our most telomeric amplicon to the gene GTF2H4, and another,
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between HLA-A and HLA-B as heterozygous sequences were found from
HCGIX-4 to HLA-E and homozygous throughout the rest of the region. An
additional 20 cell lines were chosen from members of five selected pedigrees,
which, by combining family relationships and HLA typing data, allowed for the
resolution of individual haplotypes for the four parental chromosomes and in
one case the additional grandparental chromosome. All of the sequence data and
derivative SNP typings were resolved into phases either as homozygous
sequences from the IBD lines or from segregation analysis in informative
families. In the latter, in which all members of a family were heterozygous,
which accounted for less than 2% of the SNP positions identified, it was not
possible to assign SNPs to haplotypes and the haplotype was inferred to be
consistent with the most common of the other unambiguous haplotype data
available in the typing set. From this group, three haplotypes representing the
HLA-A1, B8, DR3 (referred to here as the 8.1 haplotype) were available. To
focus specifically on 8.1, this number was supplemented for analysis by eight
additional homozygous 8.1 individuals (not derived from consanguineous
matings). To quantify the number of rare SNPs in the class III region, 282
anonymous DNAs from healthy individuals were used.
Primer design and amplicons sampled for MHC variability
Amplicons were generated by defining PCR primers derived from the
genomic template that yielded robust products of the predicted size first from
27 (MHC) identical by descent cell lines. Our goal then was to define
amplicons spread throughout the MHC at a relatively even spacing that
would together comprise a significant portion of the MHC but still stay
within the limits of practical cost constraints. Primer pairs were designed to
amplify intervals from 800 bp to 1.2 kb, using the completed MHC
consensus as template [2] using software developed in-house that
incorporated the fundamentals of Primer3 [42]. Repetitive regions were
avoided by the use of RepeatMasker [43] and polynucleotide and
multisatellite sequences were avoided or directed toward the center of
amplicons. No preference was given to genes or noncoding regions, although
all of the sequences examined were unique or low repetitive and included
promoter, enhancer, multispecies conserved sequences [44,45], and other
unique sequences of unknown function. Primer pairs were tested first on
DNAs from 4 individual cell lines to determine whether they were capable
of generating reliable and robust products (amplicons) and derivative
sequence data. About 80% of all primer pairs passed this phase and were
then used to generate PCR products and sequences from the remaining 44
cell lines. Of the 20% that failed one or more DNAs in the initial test, a
single redesign was able to recover 75% of these, resulting in an overall
success rate of 95%. These percentages did not apply to the highly
polymorphic regions of the MHC such as that near HLA-B and -C [26],
where many of the primers worked well on IBD DNAs but suffered from
allele dropout due to having been derived from sequences that were
polymorphic, resulting in preferential amplification of certain haplotypes.
Over the MHC region examined, this occurred in 58 of the 576 amplicons
designed (those that passed the initial test set of 4). Data from families
derived from these amplicons were not included in the analysis reported
here. This group of highly diverged amplicons included up to 167 SNPs/kb,
which derived unambiguously from the group of 27 IBD DNAs. The primer
sequences are available in the online supplementary material.
Sequence analysis for SNP discovery and genotyping
Resequencing for SNP discovery and genotyping was done with high-
throughput methods that used Beckman Fx robots for PCR assembly and for
sequence reaction assembly and ABI 3730xl sequencers for analysis, essentially
according to the manufacturer's instructions and to well-established basic
procedures [46]. Briefly, PCRs were assembled in a PCR clean room using a
Beckman Fx robot according to strategies facilitated and automated by software
built in the lab referred to as a Genetics Management System (GeMS) and
modified substantially over previously developed software and concepts [47].
This system was used for experimental design, laboratory procedure tracking,
and data storage in a relational database and as a framework for other exiting
data analysis tools used throughout all phases of a resequencing project. Thissystem allowed precise control over the laboratory flow and was essential in
establishing an overall low frequency of genotyping failures when using
sequencing. In these studies, the failure rate was 1%, while the genotyping error
rate (as judged by independent genotyping of the same samples) was less than
0.2%. The sample failure rate is considerably better than many fixed-platform
technologies and the error rate compares very favorably. PCR products were
treated with Exo-SAP and cycle sequencing reactions assembled from PCRs
using a Beckman Fx robot were performed in 96-well thermocyclers (Perkin–
Elmer 9700 or 2700) using cycle sequencing kits and protocols developed by
PE-Applied Biosystems (BigDye V3.1) at between 1/8 and 1/24 reaction per
sample. Reaction products were filtered through Sephadex columns and trace
data were collected on an ABI 3700 or ABI 3730xl and chromatograms
transferred automatically to an established database (GeMS).
SNP base-calling from sequence trace data
Both homozygous and heterozygous traces from each amplicon were first
combined and analyzed for sequence content using Phred and Phrap [48] and
data viewed using Consed [49]. A significant step toward making a
sequencing project of this size manageable in a small lab was the in-lab
development of a program for heterozygous sequence analysis (heterozygous
trace resolution or HTR), which was able to perform most of the analysis of
sequence-based SNP discovery and typing for heterozygous DNAs. This
software is similar in intent to Polyphred [50] and Mutation Surveyor by Soft
Genetics, LLC, and is specifically adapted for high-throughput analysis. We
first tested the program on a subset of 26 amplicons, encompassing 389
polymorphic positions. These tests demonstrated that HTR was able to reduce
the number of genotype errors made by other solutions by well over an order
of magnitude, making only 5% as many false-positive position calls and
improving on the rate of false-negative calls by a factor of 2 (false-negative
calls were near zero in this comparison). Given the extent to which these
error types are time consuming to correct manually, these improvements
provide substantial productivity gains.
To provide a more comprehensive examination of the HTR interpretation of
heterozygous data, all of the ambiguities found were resolved by manual
interpretation. Of the 21 chromosomes contained within the five families, 18
were present in at least two individuals, providing an internal check of
consistency of data calls. The known HLA type of each cell line was used to
infer the phase for each family chromosome using locally written software. We
identified 152 of 92,700 genotypes—or 0.2%—in which the duplicate-
sequenced chromosomes were given different base calls by either the HTR
software or manual interpretation. This value was essentially the same as we
have previously experienced when independently analyzing the same sample by
manual trace interpretations. All genotype positions conformed to expected
Mendelian inheritance patterns within families.
LDI, haplotype blocks, and identification of tagged amplicons
The method of computing the LDI was developed to quantify genetic
diversity at multiple loci and may be thought of as an extension of the traditional
measurement of D′. In this analysis we used LDI to measure LD between
amplicons, each of which includes multiple SNPs. Suppose an array of multiple
SNPs (A1–A2–…–Ap) from an amplicon A and multiple SNPs (B1–B2–…–Bq)
from an amplicon B, given the primary objective to measure LDI between these
two amplicons, we computed their entropies, denoted as
EA ¼ 
X
i
pAi log ðpAiÞ and EB ¼ 
X
i
pBi log ðpBiÞ;
where p is the haplotype frequency for associated haplotypes. Now one can also
compute their joint entropy EAB, for joint haplotypes of A and B. Under the null
hypothesis that amplicons A and B are at linkage equilibrium (LE), the joint
diversity is maximized and equals the summation of individual entropies, i.e.,
Emax = EA + EB. If both amplicons are at perfect LD, their joint entropy would be
minimized, and its value is denoted as Emin. The observed entropy, EAB, falls
between Emin and Emax. Therefore, if we define LDI as
LDIðA BÞ ¼ Emax  EAB
Emax  Emin ; ð1Þ
LDI is within the range (0,1) with value 0 under LE and value 1 under perfect LD.
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than using pair-wise measurement D′ as did Gabriel et al. [51]. A major
difference specific to this analysis is the building of haplotype blocks directly
from amplicons rather than SNPs. In that case each amplicon consisting of
multiple alleles is measured for LDI with neighboring amplicons and grouped
into a single block if LD as computed by the χ2 test is calculated as high.
Following this definition, the basic procedure systematically tests if an adjacent
amplicon should be merged into the existing haplotype block. The rejection of
the null hypothesis of LE implies that the amplicon should be concatenated into
the block currently being tested due to LD with the block. Otherwise, a new
block is formed starting at that amplicon.
Due to high LD among amplicons within the block, fewer amplicons are
actually needed to re-create the entire haplotype block such that there is virtually
no or nonsignificant loss of genetic diversity within the blocks. To identify such a
set of haplotype-tagging ampliconswithin each block,we systematically compute
entropy values with one amplicon being deleted at a time and leave that amplicon
only if the deletion of that amplicon does not reduce the original entropy with all
amplicons within the block by, e.g., 5%. Applying this procedure to all of the
amplicon-based haplotype blocks, we can identify such a set of “tagged
amplicons.” It is important to note that the set of tagged amplicons is not unique.
Among those equivalent sets, one can choose the “preferred set” per selection
criteria, such as experimental robustness. This procedure, together with the one
for detecting haplotype blocks, has been applied to analyze HapMap project data
and will be reported separately (personal communication, L. P. Zhao).
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